Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Deregulation of protein translation is implicated in cancer.
• MicroRNAs regulate gene expression, but their role in disrupting translation initiation complexes is unclear.

Purpose of the Study:

• To investigate the role of microRNA miR-520c-3p in cancer development.
• To determine if miR-520c-3p targets translation initiation factors and affects cell proliferation and senescence.

Main Methods:

• Overexpression of miR-520c-3p in HeLa and Diffuse Large B-cell Lymphoma (DLBCL) cells.
• Target validation using mRNA and protein analysis of eukaryotic initiation factor 4H (eIF4GII).
• In vitro and in vivo assays including cell proliferation, colony formation, senescence induction, and xenograft mouse models.
• Validation in patient-derived DLBCL samples.

Main Results:

• Elevated miR-520c-3p repressed global translation, inhibited cell proliferation, and induced premature senescence.
• miR-520c-3p directly targeted eIF4GII mRNA, reducing eIF4GII protein synthesis.
• miR-520c-3p overexpression diminished colony formation and reduced tumor growth in vivo.
• Downregulation of eIF4GII mimicked the effects of miR-520c-3p.
• DLBCL patient samples showed low miR-520c-3p and high eIF4GII expression.

Conclusions:

• miR-520c-3p acts as a tumor suppressor by repressing translation and inducing senescence.
• eIF4GII is a key mediator of miR-520c-3p's anti-tumor activity.